Phase 1b/2 Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma

Trial Profile

Phase 1b/2 Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 21 Jul 2016

At a glance

  • Drugs Vorinostat (Primary) ; Docetaxel; Gemcitabine; Pegfilgrastim
  • Indications Soft tissue sarcoma
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms GemTax
  • Most Recent Events

    • 24 Jun 2013 New trial record
    • 01 Jun 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top